Holen Sie sich die Stockscreener-App
60.84
0.60%
0.54
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bristol Myers Squibb Co Aktie (BMY) Neueste Nachrichten
Bristol Myers Squibb’s Reblozyl meets trial goals for alpha-thalassemia - Investing.com
Bristol-Myers Squibb (BMY) Gets Price Target Raise by Piper Sand - GuruFocus
BMY: Promising Phase 2 Results for Reblozyl in Alpha-Thalassemia Study - GuruFocus
Large-Cap Stock Analysis 2026: Vertiv, HCA Healthcare, Bristol-Myers SquibbNews and Statistics - IndexBox
China Universal Asset Management Co. Ltd. Purchases New Stake in Bristol Myers Squibb Company $BMY - Defense World
Down 25%, Should You Buy the Dip on Bristol Myers Squibb? - The Motley Fool
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026? - The Globe and Mail
Prothena Q4 Earnings Meet Estimates, Pipeline Progress in Focus - Finviz
This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday - Benzinga
Barclays initiates Bristol-Myers Squibb stock coverage at overweight - Investing.com
ICICI Prudential Asset Management Co Ltd Grows Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Stem Cell and Regenerative Therapy Markets, 2022-2025 & - GlobeNewswire
Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading CompaniesGilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More - Yahoo Finance
Barclays initiates Bristol-Myers Squibb stock coverage at overweight By Investing.com - Investing.com UK
Texas sues Sanofi for allegedly 'bribing' providers to boost drug prescriptions - Reuters
What Does the Street Have to Say About Bristol-Myers Squibb Company (BMY)? - Finviz
Starton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma - GlobeNewswire Inc.
Bristol Myers Squibb (NYSE:BMY) Delivers Stability While S&P 500 Stays Volatile - Kalkine Media
FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma - Finviz
Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development - Yahoo Finance
Bristol-Myers Squibb Co (NYSE:BMY) Offers a High Yield and Durable Dividend for Income Investors - ChartMill
We Like Bristol-Myers Squibb's (NYSE:BMY) Earnings For More Than Just Statutory Profit - simplywall.st
FDA accepts BMS protein degrader for review; Disc rare disease drug rejected - Yahoo Finance
Bristol Myers Squibb Company $BMY Shares Sold by Public Sector Pension Investment Board - MarketBeat
Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight – Company AnnouncementFT.com - Financial Times
Iberdomide FDA Milestone Puts Fresh Focus On Bristol Myers Squibb Hematology - Yahoo Finance
U.S. FDA accepts Bristol Myers Squibb's NDA for iberdomide in multiple myeloma - marketscreener.com
Can BMY's Growth Portfolio Counter Legacy Drugs Decline in 2026? - TradingView
Bristol Myers Squibb gains FDA nod for multiple myeloma drug - Traders Union
FDA accepts Bristol Myers Squibb’s new drug application for iberdomide - Investing.com
Vanguard Group Inc. Has $8.84 Billion Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
FDA accepts Bristol Myers Squibb’s new drug application for iberdomide By Investing.com - Investing.com Canada
Bristol-Myers Squibb's Marketing Application for Cancer Therapy Accepted for Review by FDA - marketscreener.com
U.S. Food and Drug Administration accepts Bristol Myers Squibb's new drug application for iberdomide - marketscreener.com
Skandinaviska Enskilda Banken AB publ Has $167.77 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
Colrain Capital LLC Has $8.03 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead? - Finviz
Bristol Myers Squibb Company $BMY Shares Acquired by M&G PLC - MarketBeat
Bristol Myers Squibb Company $BMY Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat
PNC Financial Services Group Inc. Sells 480,848 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Shell Asset Management Co. Has $1.52 Million Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Assetmark Inc. Buys 34,057 Shares of Bristol Myers Squibb Company $BMY - Defense World
Bristol-Myers Squibb (BMY) Stock Analysis: Is Its 4.15% Dividend Yield Enough for Investors? - DirectorsTalk Interviews
Short Interest in Bristol Myers Squibb Company (NYSE:BMY) Drops By 19.1% - MarketBeat
Berkshire Asset Management LLC PA Trims Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Acquired by Aberdeen Group plc - MarketBeat
Bristol-Myers Squibb Co (BMY) Stock Price, Trades & News - GuruFocus
Bristol Myers (BMY) Receives FDA Orphan Drug Status for Follicul - GuruFocus
Bristol-Myers Squibb Earnings Strength And Pipeline Shape Future Valuation - simplywall.st
Here's What Analysts Are Saying About Bristol-Myers Squibb Company (BMY) - Finviz
Here’s What Analysts Are Saying About Bristol-Myers Squibb Company (BMY) - Insider Monkey
Bristol Myers Squibb signs to Life Science Cares National Campaign to advance health equity and fight food insecurity - ROI-NJ
Caprock Group LLC Invests $2.99 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Stock Holdings Lessened by Cibc World Market Inc. - MarketBeat
What Does the Market Think About Bristol-Myers Squibb Co? - Benzinga
LSV Asset Management Purchases 138,119 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Sold by Rhumbline Advisers - MarketBeat
Krilogy Financial LLC Grows Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company (NYSE:BMY) Given Average Rating of "Hold" by Brokerages - MarketBeat
Illinois Municipal Retirement Fund Increases Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Caisse Des Depots ET Consignations Sells 21,113 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb Company (BMY) Growth Portfolio Driving Earnings Growth - Insider Monkey
0.78%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):